Invitae (NVTA:NYSE) Investor Relations Material

Overview

San Francisco-based Invitae Corporation, a genetic testing and medical genetics firm, has expanded its reach beyond the United States and Canada to offer its services internationally. The company's genetic tests cover a range of clinical areas, including hereditary cancer, rare diseases, women's health, and precision oncology. Invitae Corporation also provides digital health solutions and health data services to patients, healthcare providers, biopharma companies, and other partners. Previously known as Locus Development, Inc., the firm changed its name to Invitae Corporation in 2012. Since its incorporation in 2010, Invitae Corporation has been at the forefront of improving healthcare by providing breakthrough genetic information.

Frequently Asked Questions

What is Invitae's ticker?

Invitae's ticker is NVTA

What exchange is Invitae traded on?

The company's shares trade on the NYSE stock exchange

Where are Invitae's headquarters?

They are based in San Francisco, California

How many employees does Invitae have?

There are 1001-5000 employees working at Invitae

What is Invitae's website?

It is ir.invitae.com/investor-relations/default.aspx

What type of sector is Invitae?

Invitae is in the Healthcare sector

What type of industry is Invitae?

Invitae is in the Medical Laboratories & Research industry

Who are Invitae's peers and competitors?

The following five companies are Invitae's industry peers:

- Neo Performance Materials

- OpGen

- Bruker

- RadNet

- Quest Diagnostics